In the gastrointestinal tract, GLP-1 binding to its receptors delays gastric emptying, reduce appetite, and increase satiety [11]
Women consistently report this as the first noticeable effect, typically within 10 to 18 days of starting the protocol
However, the reduction in the METH intake observed in the present study cannot be solely attributed to a general suppression of operant behavior, because inactive nose-poke responding increased following liraglutide treatment in the short-access, while in the extended-access study, this effect was not evident
This distinction is fundamentally important
Clinical Evidence Guiding Provider Selection Between Platforms Research on GLP-1 prescribing emphasizes that provider oversight, regular monitoring, and dose titration reduce side-effect discontinuation rates